A 48-year-old man presented with a two-month history of progressive shortness of breath and fatigue, which was significantly worse over the last week.


Acute Myeloid Leukemia Acute Promyelocytic Leukemia Retinoic Acid Receptor Arsenic Trioxide Hematologic Neoplasm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Wang ZY, Chen Z. Acute promyelocytic leukemia: From highly fatal to highly curable. Blood 2008;111:2505–2515.CrossRefPubMedGoogle Scholar
  2. 2.
    Sun T. Flow Cytometry and Immunohistochemistry for Hematologic Neoplasms. Philadelphia, Lippincott Williams & Wilkins, 2008, 86–92.Google Scholar
  3. 3.
    Golomb HM, Rowley JD, Vardiman JW, et al. “Microgranular” acute promyelocytic leukemia: A distinct clinical, ultrastructural and cytogenetic entity. Blood 1980;55:253–259.PubMedGoogle Scholar
  4. 4.
    Rizzatti EG, Garcia AB, Pothan H, et al. Expression of CD117 and CD11b in bone marrow can differentiate acute promyelocytic leukemia from recovering myeloid proliferations. Am J Clin Pathol 2002;118:31–37.CrossRefPubMedGoogle Scholar
  5. 5.
    Falini B, Flenghi L, Fagioli M, et al. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). Blood 1997;90:4046–4053.PubMedGoogle Scholar
  6. 6.
    Lo Coco F, Diverio D, Falini B, et al. Genetic diagnosis and molecular monitoring in the management of acute promyelocytic leukemia. Blood 1999;94:417–428.Google Scholar
  7. 7.
    Arber DA, Brunning RD, Le Beau MM, et al. Acute myeloid leukemia with recurrent genetic abnormalities. In Swerdlow SH, Campo E, Harris NL, et al. eds., WHO Classification of Tumours of Heamatopoietic and Lymphoid Tissues. 4th ed. Lyon, France, 2008, 112–114.Google Scholar
  8. 8.
    Marasca R, Maffei R, Zucchini P, et al. Gene expression profiling of acute promyelocytic leukemia identified two subtypes mainly associated with Flt3 mutational status. Leukemia 2006;20:103–114.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Personalised recommendations